Literature DB >> 3087182

Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome.

J C Harris, D F Wong, H N Wagner, A Rett, S Naidu, R F Dannals, J M Links, M L Batshaw, H W Moser.   

Abstract

We report on the first positron emission tomographic study of dopamine receptor binding in Rett syndrome. The patient is a 25 year old Austrian woman diagnosed at age 2 and followed since then by Rett. A computed axial tomogram (CT scan) showed cortical atrophy, and enlarged ventricles but normal structure of the caudate/putamen. Following the CT scan 20 mCi of 11 C N-methyl spiperone, a butyrophenone with a high affinity for dopamine D2 receptors was administered intravenously. The patient was found to have dopamine D2 receptor binding activity in the low normal range. The caudate/cerebellar activity ratio was below the mean regression line (p = 0.10) that relates the CA/CB ratio as a function of age. Levels of cerebrospinal fluid neurotransmitter metabolites were normal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087182     DOI: 10.1002/ajmg.1320250523

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  5 in total

Review 1.  Rett syndrome: a review of current knowledge.

Authors:  R Van Acker
Journal:  J Autism Dev Disord       Date:  1991-12

Review 2.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 3.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

4.  Deficient Purposeful Use of Forepaws in Female Mice Modelling Rett Syndrome.

Authors:  Bianca De Filippis; Mattia Musto; Luisa Altabella; Emilia Romano; Rossella Canese; Giovanni Laviola
Journal:  Neural Plast       Date:  2015-06-22       Impact factor: 3.599

5.  Decreased Brain Ventricular Volume in Psychiatric Inpatients with Serotonin Reuptake Inhibitor Treatment.

Authors:  P K Bolin; S N Gosnell; K Brandel-Ankrapp; N Srinivasan; A Castellanos; R Salas
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.